Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
suicide risk
Pharma
Study suggests possible suicidal ideation link to Novo's Ozempic
The study adds to swirling concerns over the drug's safety profile that led to FDA and EMA investigations, both of which found no such suicide link.
Zoey Becker
Aug 20, 2024 4:49pm
EU regulator finds no link between GLP-1s and suicidal thoughts
Apr 12, 2024 11:06am
No evidence of suicidal risk with Novo, Lilly GLP-1s, FDA says
Jan 12, 2024 10:26am
Study says no link with Novo’s GLP-1 drugs and suicidal ideation
Jan 5, 2024 11:14am
FDA examining side-effect reports with Lilly, Novo obesity drugs
Jan 4, 2024 11:33am
EMA will monitor suicide risk in Novo Nordisk's GLP-1 products
Jul 10, 2023 11:11am
